Other

Pfizer 2Q net income rises 25 pct on lower costs

Drugmaker Pfizer Inc.'s second-quarter net income jumped 25 percent as sharply lower costs for production, marketing and restructuring more than offset a plunge in revenue from cholesterol fighter Lipitor due to increasing ...

Medications

'Generic' medical devices could cut into name-brand profits

Generic competition - a billion-dollar problem for brand-name drug companies since the 1980s - is making inroads in the orthopedic medical devices industry. Last week Cardinal Health Inc., one of the three biggest device ...

Health

Philip Morris sues Norway over tobacco display ban

Global tobacco giant Philip Morris began a suit Monday against Norway, claiming that the Scandinavian country's ban on the display of cigarettes in stores violates European competition rules.

Psychology & Psychiatry

Jealousy and envy at work are different in men and women

A study carried out by researchers from Spain, the Netherlands and Argentina suggests that in a work environment, sexual competition affects women more than men. However, a rival's social skills provoke jealousy and professional ...

Medications

FDA outlines path for lower-priced biotech drugs

(AP) -- The Food and Drug Administration is preparing to review the first lower-cost versions of biotech drugs, expensive medications which have never before faced generic competition.

Psychology & Psychiatry

Is there a dark side to moving in sync?

Moving in harmony can make people feel more connected to one another and, as a result, lead to positive collective action. Think of those feel-good vibes created in a yoga class as students move in unison through their downward-facing ...

Medications

With new generic rivals, Lipitor's sales halved

Sales of cholesterol blockbuster Lipitor plunged by half barely a week after the world's top-selling drug got its first U.S. generic competition, new data show.

Medications

Pfizer maneuvers to protect Lipitor from generics

(AP) -- Lipitor is so valuable that its maker, Pfizer Inc., is practically paying people to keep taking the blockbuster cholesterol medicine after generic competition hits the U.S. market this week.

page 15 from 16